88 related articles for article (PubMed ID: 18685694)
1. Alzheimer's disease: The latest suspect.
Tanzi RE; Bertram L
Nature; 2008 Aug; 454(7205):706-8. PubMed ID: 18685694
[No Abstract] [Full Text] [Related]
2. Linking calcium to Abeta and Alzheimer's disease.
Green KN; LaFerla FM
Neuron; 2008 Jul; 59(2):190-4. PubMed ID: 18667147
[TBL] [Abstract][Full Text] [Related]
3. No association between CALHM1 polymorphism and Alzheimer's disease risk in a Hungarian population.
Fehér A; Juhász A; Rimanóczy A; Pákáski M; Kálmán J; Janka Z
Psychiatr Genet; 2011 Oct; 21(5):249-52. PubMed ID: 21378601
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology. Trafficking protein suspected in Alzheimer's disease.
Marx J
Science; 2007 Jan; 315(5810):314. PubMed ID: 17234920
[No Abstract] [Full Text] [Related]
5. Alzheimer's disease. Fresh evidence points to an old suspect: calcium.
Marx J
Science; 2007 Oct; 318(5849):384-5. PubMed ID: 17947560
[No Abstract] [Full Text] [Related]
6. Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein.
Kawahara M; Negishi-Kato M; Sadakane Y
Expert Rev Neurother; 2009 May; 9(5):681-93. PubMed ID: 19402778
[TBL] [Abstract][Full Text] [Related]
7. No association between CALHM1 and risk for Alzheimer dementia in a Belgian population.
Sleegers K; Brouwers N; Bettens K; Engelborghs S; van Miegroet H; De Deyn PP; Van Broeckhoven C
Hum Mutat; 2009 Apr; 30(4):E570-4. PubMed ID: 19191332
[TBL] [Abstract][Full Text] [Related]
8. Update on amyloid-beta homeostasis markers for sporadic Alzheimer's disease.
Zetterberg H
Scand J Clin Lab Invest; 2009; 69(1):18-21. PubMed ID: 19199126
[TBL] [Abstract][Full Text] [Related]
9. Calcium homeostasis modulator 1 gene P86L polymorphism and the risk for alzheimer's disease: A meta-analysis.
Mun MJ; Kim JH; Choi JY; Jang WC
Neurosci Lett; 2016 Apr; 619():8-14. PubMed ID: 26944452
[TBL] [Abstract][Full Text] [Related]
10. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
[TBL] [Abstract][Full Text] [Related]
11. ACAT1 is not associated with Alzheimer's disease in two independent family-based samples.
Bertram L; Hsiao M; Mullin K; Parkinson M; Menon R; Moscarillo TJ; Blacker D; Tanzi RE
Mol Psychiatry; 2005 Jun; 10(6):522-4. PubMed ID: 15768051
[No Abstract] [Full Text] [Related]
12. Association between the polymorphisms of CALHM1 and GOLPH2 genes and Alzheimer's disease.
Lin K; Tang M; Han H; Guo Y; Lin Y; Ma C
Psychiatr Genet; 2010 Aug; 20(4):190. PubMed ID: 20592574
[No Abstract] [Full Text] [Related]
13. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
14. Rare variants in calcium homeostasis modulator 1 (CALHM1) found in early onset Alzheimer's disease patients alter calcium homeostasis.
Rubio-Moscardo F; Setó-Salvia N; Pera M; Bosch-Morató M; Plata C; Belbin O; Gené G; Dols-Icardo O; Ingelsson M; Helisalmi S; Soininen H; Hiltunen M; Giedraitis V; Lannfelt L; Frank A; Bullido MJ; Combarros O; Sánchez-Juan P; Boada M; Tárraga L; Pastor P; Pérez-Tur J; Baquero M; Molinuevo JL; Sánchez-Valle R; Fuentes-Prior P; Fortea J; Blesa R; Muñoz FJ; Lleó A; Valverde MA; Clarimón J
PLoS One; 2013; 8(9):e74203. PubMed ID: 24069280
[TBL] [Abstract][Full Text] [Related]
15. The molecular and cellular pathogenesis of dementia of the Alzheimer's type an overview.
Luque FA; Jaffe SL
Int Rev Neurobiol; 2009; 84():151-65. PubMed ID: 19501717
[TBL] [Abstract][Full Text] [Related]
16. [CALHM1, a novel gene to blame in Alzheimer disease].
Lambert JC; Campagne F; Marambaud P
Med Sci (Paris); 2008 Nov; 24(11):923-4. PubMed ID: 19038093
[No Abstract] [Full Text] [Related]
17. Aluminum modulates effects of beta amyloid(1-42) on neuronal calcium homeostasis and mitochondria functioning and is altered in a triple transgenic mouse model of Alzheimer's disease.
Drago D; Cavaliere A; Mascetra N; Ciavardelli D; di Ilio C; Zatta P; Sensi SL
Rejuvenation Res; 2008 Oct; 11(5):861-71. PubMed ID: 18788899
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
19. A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.
Dreses-Werringloer U; Lambert JC; Vingtdeux V; Zhao H; Vais H; Siebert A; Jain A; Koppel J; Rovelet-Lecrux A; Hannequin D; Pasquier F; Galimberti D; Scarpini E; Mann D; Lendon C; Campion D; Amouyel P; Davies P; Foskett JK; Campagne F; Marambaud P
Cell; 2008 Jun; 133(7):1149-61. PubMed ID: 18585350
[TBL] [Abstract][Full Text] [Related]
20. Analysis of APBB2 gene polymorphisms in sporadic Alzheimer's disease.
Golanska E; Sieruta M; Gresner SM; Hulas-Bigoszewska K; Corder EH; Styczynska M; Peplonska B; Barcikowska M; Liberski PP
Neurosci Lett; 2008 Dec; 447(2-3):164-6. PubMed ID: 18852029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
